{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T21:38:02Z","timestamp":1775770682730,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FIS PI18\/00718"],"award-info":[{"award-number":["FIS PI18\/00718"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.humimm.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:25:48Z","timestamp":1695921948000},"page":"571-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Coronavirus-19 disease risk and protective factors associated with HLA\/KIR polymorphisms in Ecuadorian patients residing in Madrid"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-3304","authenticated-orcid":false,"given":"Antonio","family":"Balas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Moreno-Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"de la Calle-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-3728","authenticated-orcid":false,"given":"Marta","family":"Arsuaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"de Miguel-Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-6879","authenticated-orcid":false,"given":"Teresa","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9427-5237","authenticated-orcid":false,"given":"Marta","family":"D\u00edaz-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2023.09.004_b0005","unstructured":"WHO Coronavirus (COVID-19) Dashboard. Available from: https:\/\/covid19.who.int. 1 March 2023, date last accessed."},{"key":"10.1016\/j.humimm.2023.09.004_b0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","article-title":"Viral and host factors related to the clinical outcome of COVID-19","volume":"583","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2023.09.004_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevImmunol.v37.i2-6.10","article-title":"The Nature of Selection on the Major Histocompatibility Complex","volume":"37","author":"Apanius","year":"2017","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0020","doi-asserted-by":"crossref","unstructured":"K. Mackey, C.K. Ayers, K.K. Kondo et al., Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths: A Systematic Review, Ann. Intern. Med. 174 (202), 362\u2013373.","DOI":"10.7326\/M20-6306"},{"key":"10.1016\/j.humimm.2023.09.004_b0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40001-021-00563-1","article-title":"Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature","volume":"26","author":"Migliorini","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.humimm.2023.09.004_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tan.14284","article-title":"The influence of HLA genotype on the severity of COVID-19 infection","volume":"98","author":"Langton","year":"2021","journal-title":"HLA"},{"key":"10.1016\/j.humimm.2023.09.004_b0035","doi-asserted-by":"crossref","first-page":"e0272867\/","DOI":"10.1371\/journal.pone.0272867","article-title":"Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort","volume":"17","author":"Vig\u00f3n","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2023.09.004_b0040","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)05117-5","article-title":"Immunogenetics and genomics","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2023.09.004_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-60327-118-9_21","article-title":"HLA-peptide binding prediction using structural and modeling principles","volume":"409","author":"Kangueane","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.humimm.2023.09.004_b0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0055","first-page":"15","article-title":"HLA Variation and SARS-CoV-2 Specific Antibody Response","author":"Wolday","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.humimm.2023.09.004_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102178","article-title":"HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection","volume":"76","author":"Augusto","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","article-title":"Natural killer cells as an initial defense against pathogens","volume":"18","author":"Lodoen","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000324176","article-title":"Natural killer cell responses to viral infection","volume":"3","author":"Brandstadter","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.humimm.2023.09.004_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0080","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/JVI.06209-11","article-title":"Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2023.09.004_b0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fcimb.2020.00425","article-title":"Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection","volume":"10","author":"Frank","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.humimm.2023.09.004_b0090","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/eji.201242620","article-title":"NK cells exacerbate the pathology of influenza virus infection in mice","volume":"43","author":"Zhou","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0095","doi-asserted-by":"crossref","first-page":"733.e9","DOI":"10.1016\/j.cmi.2016.05.009","article-title":"Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection","volume":"22","author":"Ghosh","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.humimm.2023.09.004_b0100","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.humimm.2013.05.007","article-title":"Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma","volume":"74","author":"Littera","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cll.2018.08.001","article-title":"Diversity of Killer Cell Immunoglobulin-Like Receptors and Disease","volume":"38","author":"Rajalingam","year":"2018","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.humimm.2023.09.004_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108682","article-title":"NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases","volume":"107","author":"Hojjatipour","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2023.09.004_b0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20050499","article-title":"Understanding how combinations of HLA and KIR genes influence disease","volume":"201","author":"Rajagopalan","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2023.09.004_b0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","article-title":"KIR and disease: a model system or system of models?","volume":"214","author":"Khakoo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2023.09.004_b0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/v12111333","article-title":"Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality","volume":"12","author":"Sakuraba","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.humimm.2023.09.004_b0140","article-title":"The KIR2DL2\/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.845474","article-title":"Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19","volume":"13","author":"Maruthamuthu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.humimm.2023.09.004_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102027","article-title":"Presenting characteristics and outcomes of migrants in a cohort of hospitalized patients with COVID-19: Does the origin matter?","volume":"42","author":"D\u00edaz-Men\u00e9ndez","year":"2021","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.humimm.2023.09.004_b0155","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","author":"Marshall","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.humimm.2023.09.004_b0160","doi-asserted-by":"crossref","first-page":"D1053","DOI":"10.1093\/nar\/gkac1011","article-title":"The IPD-IMGT\/HLA Database","volume":"51","author":"Barker","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2023.09.004_b0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism","volume":"190","author":"Hsu","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2023.09.004_b0170","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1084\/jem.184.3.913","article-title":"Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules","volume":"184","author":"Mandelboim","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2023.09.004_b0175","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2023.09.004_b0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/tan.13956","article-title":"Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide","volume":"96","author":"Barquera","year":"2020","journal-title":"HLA"},{"key":"10.1016\/j.humimm.2023.09.004_b0185","doi-asserted-by":"crossref","first-page":"e00510","DOI":"10.1128\/JVI.00510-20","article-title":"Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2023.09.004_b0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.humimm.2022.09.008","article-title":"In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2","volume":"83","author":"Rao","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-4-9","article-title":"Association of HLA class I with severe acute respiratory syndrome coronavirus infection","volume":"4","author":"Lin","year":"2003","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.humimm.2023.09.004_b0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.humimm.2022.09.004","article-title":"HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection","volume":"83","author":"Hernandez","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.medin.2020.08.004","article-title":"HLA genetic polymorphisms and prognosis of patients with COVID-19","volume":"45","author":"Lorente","year":"2021","journal-title":"Med. Intensiva"},{"key":"10.1016\/j.humimm.2023.09.004_b0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-0039.2010.01578.x","article-title":"Allelic and haplotypic HLA frequency distribution in Spanish hematopoietic patients. Implications for unrelated donor searching","volume":"77","author":"Balas","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2023.09.004_b0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.12688\/f1000research.51479.1","article-title":"Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses","volume":"10","author":"Dijkstra","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.humimm.2023.09.004_b0220","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijid.2020.05.033","article-title":"Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population","volume":"96","author":"Auer","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.humimm.2023.09.004_b0225","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3389\/fimmu.2017.01912","article-title":"The Clinical Features of Patients with Chronic Hepatitis C Virus Infections Are Associated with Killer Cell Immunoglobulin-Like Receptor Genes and Their Expression on the Surface of Natural Killer Cells","volume":"8","author":"Podhorzer","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAD.0000000000000574","article-title":"The HLA-C*04: 01\/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression","volume":"29","author":"Olvera","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2023.09.004_b0235","doi-asserted-by":"crossref","first-page":"e99353","DOI":"10.1371\/journal.pone.0099353","article-title":"KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function","volume":"9","author":"Merino","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2023.09.004_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.769900","article-title":"HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity","volume":"13","author":"Hovhannisyan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108911","article-title":"Association of KIR gene polymorphisms with COVID-19 disease","volume":"234","author":"Hajeer","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2023.09.004_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102416","article-title":"Relationship between KIR genotypes and HLA-ligands with SARS-CoV-2 infection in the Saudi population","volume":"35","author":"Alomar","year":"2023","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.humimm.2023.09.004_b0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jiab228","article-title":"Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019","volume":"224","author":"Bernal","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.humimm.2023.09.004_b0260","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V122.21.1043.1043","article-title":"KIR3DL1 and HLA-Bw4 Allotypes Predict The Extent Of NK Cell Licensing","volume":"122","author":"Boudreau","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2023.09.004_b0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","article-title":"The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense","volume":"7","author":"Bashirova","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.humimm.2023.09.004_b0270","doi-asserted-by":"crossref","unstructured":"D. La, C. Czarnecki, H. El-Gabalawy et al., Enrichment of variations in KIR3DL1\/S1 and KIR2DL2\/L3 among H1N1\/09 ICU patients: an exploratory study, PLoS One 6 (201) e29200.","DOI":"10.1371\/journal.pone.0029200"},{"key":"10.1016\/j.humimm.2023.09.004_b0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12071","article-title":"Immunogenetics of HIV disease","volume":"254","author":"Martin","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2023.09.004_b0280","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888592300335X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888592300335X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:58:25Z","timestamp":1759319905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019888592300335X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S019888592300335X"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.09.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronavirus-19 disease risk and protective factors associated with HLA\/KIR polymorphisms in Ecuadorian patients residing in Madrid","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}